Related Experiment Video
Updated: Oct 30, 2025

09:04
Covalent Binding of Antibodies to Cellulose Paper Discs and Their Applications in Naked-eye Colorimetric Immunoassays
Published on: October 21, 2016
14.9K
Paper-Based Immunosensors with Bio-Chemiluminescence Detection
Maria Maddalena Calabretta1,2, Martina Zangheri1, Donato Calabria1
1Department of Chemistry "Giacomo Ciamician", University of Bologna, 40126 Bologna, Italy.
Sensors (Basel, Switzerland)
|July 2, 2021
Summary
Paper-based analytical devices offer promising point-of-care diagnostics, especially with chemiluminescent immunoassays. However, challenges hinder their widespread adoption, requiring focused research for routine clinical use.
Area of Science:
- Analytical Chemistry
- Biomedical Engineering
- Diagnostics
Background:
- Paper-based analytical devices (PADs) have evolved significantly for point-of-care (POC) diagnostics.
- Chemiluminescent (CL) immunoassays adapted to paper formats show great potential for portable, on-site applications.
- PADs combined with CL detection offer a unique solution for POC testing.
Purpose of the Study:
- To review the progress and challenges in developing paper-based diagnostic devices.
- To identify the barriers preventing the widespread clinical adoption of these technologies.
- To highlight areas for future research to enable routine application of PADs.
Main Methods:
- Literature review of advancements in paper-based analytical devices.
- Analysis of chemiluminescent immunoassays integrated with paper platforms.
- Evaluation of factors limiting the translation of research into clinical practice.
Main Results:
- Significant advancements have been made in adapting analytical methods, particularly CL immunoassays, to paper substrates.
- Despite scientific progress, a gap exists between research output and the real-world implementation of these devices.
- Key issues hindering routine use include scalability, standardization, and integration into existing healthcare workflows.
Conclusions:
- Paper-based diagnostics, especially CL immunoassays, are well-suited for POC applications.
- Overcoming current limitations requires targeted research and development efforts.
- Future work should focus on addressing practical challenges to facilitate routine clinical use of these innovative diagnostic tools.

